| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918691 | Radiotherapy and Oncology | 2013 | 7 Pages |
Abstract
Post-SABR survival for early-stage NSCLC is not affected by tumour location. SABR achieves high local control with limited toxicity when appropriate fractionation schedules are used for central tumours.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sashendra Senthi, Cornelis J.A. Haasbeek, Ben J. Slotman, Suresh Senan,